Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 31,487 shares at $12.63 ($398K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Scheduled sale ($398k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-11-14 | $197K | — | Filing → |
| KURA | SELL | 2025-09-29 | $157K | — | Filing → |